MDXG FY 2020 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$248M-17.0% YoY

Gross Profit

$209M84.2% margin

Operating Income

-$45M-18.3% margin

Net Income

-$49M-19.9% margin

EPS (Diluted)

$-0.46

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$34M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$202M

Total Liabilities

$111M

Stockholders' Equity

$91M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$248M	$299M	-17.0%
Gross Profit	$209M	$256M	-18.5%
Operating Income	-$45M	-$21M	-114.5%
Net Income	-$49M	-$26M	-92.7%